Clinical Trial Update: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic body radiotherapy in combination with a focal adhesion kinase (FAK) inhibitor for advanced pancreatic adenocarcinoma; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Focal Adhesion Kinase inhibitor

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreas Cancer, Cancer of the Pancreas | Phase 2 | Status: ACTIVE_NOT_RECRUITING